Our in vitro rescue experiments revealed that TAZ functioned as a novel downstream target of USP7 to promote HNSCC progression as evidenced that reintroduction TAZ largely attenuated the biological effects of USP7 knockdown. The gene discussed is WWTR1; the disease is head and neck squamous cell carcinoma.